Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Audited financial ....
CAPLIPOINT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Caplin Point Laboratories Ltd has announced a board meeting scheduled for May 14, 2026 to consider and approve the annual audited financial results for FY 2025-26 on both standalone and consolidated basis. The meeting will also consider declaration of interim dividend for FY 2025-26 and fixation of record date for determining shareholder eligibility. This is a standard regulatory intimation under SEBI Listing Regulations. The company had earlier informed about trading window closure from April 1, 2026 to May 16, 2026 for designated persons as per insider trading norms.
This is a routine procedural filing announcing a future board meeting. The actual financial results and dividend decision will be disclosed after the meeting. Investors should await the actual results announcement for any material information about company performance.